Loading clinical trials...
Loading clinical trials...
The main goal of this study was to investigate the effectiveness and safety of eltrombopag (ETB) when compared to other treatments in Japanese aplastic anemia (AA) patients using data from the Medical...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Pharmaceuticals
NCT02065869 · Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child, and more
NCT00997386 · Hematologic Neoplasms, Multiple Myeloma, and more
NCT00229619 · Anemia, Aplastic, Red-Cell Aplasia, Pure, and more
NCT00061763 · Beta-thalassemia, Myelodysplastic Syndromes, and more
NCT00578266 · Anemia, Aplastic
Novartis
East Hanover, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions